Clinical Trials & Pipeline
Mirna is a clinical-stage biopharmaceutical company developing a broad pipeline of leading microRNA-based oncology therapeutics, the first to demonstrate clinical proof of concept for microRNA replacement therapy.
LEARN MORE ABOUT US
MRX34, Mirna’s lead product candidate, is the first microRNA mimic to enter clinical testing.
LEARN MORE ABOUT OUR CLINICAL TRIALS AND PIPELINE
October 6, 2015
Mirna Therapeutics Announces Closing of Initial Public Offering and Concurrent Private Placement with CPRIT
October 1, 2015
Mirna Therapeutics Announces Pricing of its Initial Public Offering
VIEW ALL NEWS
© 2015 Mirna Therapeutics, Inc. All Rights Reserved.